Highlights | Pfizer expanded its cost-cutting efforts and reported first-quarter profit that topped estimates, even as the company’s sales fell, largely due to dwindling revenue for its antiviral Covid pill Paxlovid.
Currency:USDApr 29, 2025
Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
Revenue | 14.05B | 13.72B | -333.38M |
Miss Est. | -5.58% | -7.82% | -2.37% |
EPS | 0.51 | 0.52 | +0.01 |
Beat Est. | -8.13% | -5.45% | +2.91% |
Apr 28, 2025
Revenue
EPS
EBIT
Revenue is based on 12 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Unlock Free Earnings Estimates
Read more